Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R. - Wikidata - awgldk - TriplyDB

Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.

Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.

http://www.wikidata.org/entity/Q37332147

about

Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development Lifestyle Modifications and Colorectal Cancer Research progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanisms Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways.The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas.Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells.Regulation of colon cancer recurrence and development of therapeutic strategies.Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy.Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo.Cancer-linked targets modulated by curcumin Chemoprevention of gastrointestinal cancer: the reality and the dream.Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens.MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers.Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature.Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model.Insulin-like growth factor: current concepts and new developments in cancer therapy.New insights into therapeutic activity and anticancer properties of curcumin.Therapeutic potential of curcumin in gastrointestinal diseases.Cancer Stem Cells: A Moving Target The aryl hydrocarbon receptor as an antitumor target of synthetic curcuminoids in colorectal cancer.Effect of curcumin on vascular endothelial growth factor in hypoxic HepG2 cells via the insulin-like growth factor 1 receptor signaling pathway.

P2860

Q24616554-9FCC5190-C56D-4B89-9AE9-17510B9645D4 Q26865414-5176B962-2CA5-4E98-A9FB-6172BE7B44CE Q28067369-9B823442-51C3-4888-A957-307613BFA2A6 Q31146840-986DF20E-38B8-4A0F-87A6-06A780D84AE6 Q33692466-108239C7-EB8D-4C37-A286-88E25B920B10 Q33772604-710CEBB6-2830-4921-91AC-25A7BF6B4004 Q35556332-7A74248D-611B-4666-850F-656E444BEC12 Q35747354-2B308399-0C09-4C97-A5C9-9A638AD2FB7F Q35772157-D9124F33-62FA-4764-AFC6-15EABC061E62 Q35876385-B76FEEC6-01B5-4435-A5AE-57AD1D066114 Q36021018-046F1748-283A-4878-B64C-B034E5EAD5D8 Q36499048-20AEB954-E562-4D3A-A0B9-BC36A7A428DF Q36715105-D9FC3C06-20A5-4971-A21C-94F6B1CB7A65 Q36723767-E32253ED-3A03-48D8-89B5-8E408642E102 Q36906199-F6B5598E-9257-4789-8BD7-722B0554ABD9 Q36956879-B4409A0E-F633-49FD-93C3-8FD6EB84DFB3 Q37011161-4C2101E7-6D6D-4F6D-A00F-CF9B3D70C17C Q37047067-D9FAD5D9-3852-4116-BD0A-B3E692B43558 Q37745657-B23CEF09-EADC-47B1-ACB0-223B01969660 Q37878888-D0005BF8-7466-4E3D-9AC5-77E2459AAA26 Q38126498-F7ED49F9-F54A-47BC-B0A9-9E24FF97634F Q50950858-B1BC992E-98E5-4C0A-B654-314A7DC4E987 Q54118581-2DA34D08-F28C-4350-B8CE-002F82124BE6

P2860

Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.

http://www.wikidata.org/entity/Q37332147

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.

@en

Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.

@nl

type

label

Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.

@en

Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.

@nl

prefLabel

Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.

@en

Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.

@nl

P1433

Q37332147-8B79B6CA-A56A-4DD6-940B-362C0286B883

P1476

Q37332147-FDC79438-C936-41D3-AFBD-8F2FD665BD76

P2093

Q37332147-25ADBB78-398B-4441-BF4B-B8FDD6322CD8

Q37332147-3174E2F5-3A3B-4518-8E42-E7CBD140F4DD

Q37332147-59DDEDAD-5F87-415A-9216-3BA388FCDB62

Q37332147-7F1367F1-80C8-4996-A531-185B98434355

Q37332147-A03D0F85-34C6-4943-B8D2-FB1AB0CD1B03

Q37332147-D2565692-9A9A-4364-98B2-EA268F159EA8

P2860

Q37332147-000B5220-25F6-483E-AD7A-DC260C1A4049

Q37332147-03A42173-94D4-420F-BA92-1C3302B8A0CA

Q37332147-06214281-BFD6-42B1-9377-AA13E14FDB1E

Q37332147-06FC62D7-FE20-49E6-9F3A-E0C6498D06ED

Q37332147-4453D4D8-2E3D-41ED-99E7-21221A2E44A5

Q37332147-5452F057-7747-4158-9D71-D384F811B5E5

Q37332147-5A6FCC54-34A6-47C4-9885-703F97FBCD71

Q37332147-660F24E8-F116-4B03-840B-30AD9EEDC174

Q37332147-85C3554A-D0EB-461A-98F7-BFBBAD324DD3

Q37332147-96DE876A-6D2B-4008-A7DB-E2303C1EC36B

P304

Q37332147-26903E50-9846-4E61-9FA5-504F4D674185

P31

Q37332147-43956060-AAC0-4C59-A844-FC8167476A5A

P407

Q37332147-899A9DC2-9A50-4CA0-BC0F-93172CC77528

P433

Q37332147-AA58804A-862B-45B6-A65D-64BDA4630FC8

P478

Q37332147-7466B965-F7FB-48D3-BF6F-96726D5A8F4B

P577

Q37332147-1676C4DB-F7B2-431A-852B-3B9A2BB29235

P698

Q37332147-48752055-27A4-426D-B622-49DDBA415B40

P921

Q37332147-d6dfd384-311b-4911-8fc1-26fc3aad39d5

P932

Q37332147-60E8F86C-11F5-4C2B-96AF-D9AC3ABAF153

P1433

Anticancer Research

P1476

Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.

@en

P2093

Adhip P N Majumdar

http://www.w3.org/2001/XMLSchema#string

Althea A Elliott

http://www.w3.org/2001/XMLSchema#string

Bhaumik B Patel

http://www.w3.org/2001/XMLSchema#string

Deepshika Gupta

http://www.w3.org/2001/XMLSchema#string

Vivek Sengupta

http://www.w3.org/2001/XMLSchema#string

Yingjie Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Cetuximab for the treatment of colorectal cancer.

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Epidermal growth factor-related peptides and their receptors in human malignancies

Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions

Chemotherapeutic potential of curcumin for colorectal cancer.

Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition.

Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy.

Cross-talk between the ErbB/HER family and the type I insulin-like growth factor receptor signaling pathway in breast cancer.

Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R.

Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib.

P304

319-325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20332435

http://www.w3.org/2001/XMLSchema#string

P921

P932

3836443

http://www.w3.org/2001/XMLSchema#string